Product Information
ESLICARBAZEPINE 400 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.8508 per EA under NDC 31722042930. Its NADAC has been published 59 times since Aug 20, 2025.
FDA first approved this application on Aug 3, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722042930
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESLICARBAZEPINE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA211186FDA Approved
8/3/2023
TE Code
AB
On Market Since
8/3/2023
Pharmacological Classes
Price Statistics
The NADAC for ESLICARBAZEPINE 400 MG TABLET has been published 59 times since Aug 20, 2025, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.8508 per EA |
|---|---|
| All-time high | $4.7606 (Sep 10, 2025) |
| All-time low | $1.8508 (Sep 23, 2026) |
| 52-week high | $4.3386 |
| 52-week low | $1.8508 |
| Median price | $3.1901 |
| Average price | $3.2865 |
| Largest weekly change | -19.1% (Aug 19, 2026) |
| Weeks tracked | 59 |
| Tracking since | Aug 20, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Eslicarbazepine acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESLICARBAZEPINE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESLICARBAZEPINE 400 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.8508 per EA (NDC 31722042930), effective Sep 30, 2026.
How has the price of ESLICARBAZEPINE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESLICARBAZEPINE 400 MG TABLET has declined 61.1%. It has been tracked across 59 weekly CMS publications since Aug 20, 2025.
What are the highest and lowest recorded NADAC prices for ESLICARBAZEPINE 400 MG TABLET?
Since Aug 20, 2025, the NADAC for ESLICARBAZEPINE 400 MG TABLET has ranged from a low of $1.8508 (Sep 23, 2026) to a high of $4.7606 (Sep 10, 2025), with a median of $3.1901 per EA.
Are there cheaper alternatives to ESLICARBAZEPINE 400 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ESLICARBAZEPINE 400 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ESLICARBAZEPINE 400 MG TABLET?
ESLICARBAZEPINE 400 MG TABLET (NDC 31722042930) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.